Our study indicates that, for lung adenocarcinoma patients with brain metastasis, a validated prognostic nomogram (KPS, smoking, EGFR-20 and Ca125) can more accurately predict the 1-year and 2-year survival of the patients before TKI therapy than other models. This evidence concerns the gene EGFR and lung adenocarcinoma.